Chondroadherin is a cell binding, leucine-rich repeat protein found in the territorial matrix of articular cartilage. Several members of the leucine-rich repeat protein family present in the extracellular matrix of e.g. cartilage have been shown to interact with collagen and influence collagen fibrillogenesis. We show that complexes of monomeric collagen type II and chondroadherin can be released under non-denaturing conditions from articular cartilage treated with p-aminophenylmercuric acetate to activate resident matrix metalloproteinases. Purified complexes as well as complexes formed in vitro between recombinant chondroadherin and collagen type II were studied by electron microscopy. Chondroadherin was shown to bind to two sites on collagen type II. 
The major constituents of the extracellular matrix of cartilage are type II collagen, proteoglycans, and a number of proteins including some of the minor collagens. The matrix macromolecules have very different structural and functional characteristics, and each component contributes differently to the organization and properties of the tissue. The matrix macromolecules are assembled in multicomponent networks where the interactions between the matrix constituents are essential for the maintenance of tissue integrity (1) .
One of the non-collagenous proteins in cartilage is chondroadherin. It was first isolated from bovine tracheal cartilage (2) . The protein and cDNA sequence of bovine chondroadherin (3) show that it belongs to the family of leucine-rich repeat (LRR) 1 proteins (4) . A subgroup of LRR proteins have several members in extracellular matrices and are characterized by a conserved sequence XLXXLXLXX(N/C/T)X(L/I) followed by 9 -14 less conserved residues. Overall, this sequence may be repeated up to 30 times, whereas in the extracellular proteins it usually occurs 10 -11 times and in other subgroups [5] [6] times. The repeat domain is flanked by two disulfide bonded loops and usually short extensions in the N-terminal and Cterminal regions of the protein. The crystal structure of one member of the LRR protein family, ribonuclease inhibitor, has been solved and refined at 2.5 Å (5). It shows that each LRR is composed of a ␤-sheet and an ␣-helix. The ␤-sheet that forms the consensus part of the LRR and the less conserved ␣-helices are exposed at different faces of the protein. Although the repeats are larger and higher in number than in the matrix proteins, it is likely that at least some features are represented in the other members of this family. A common property of the LRR proteins is that their three-dimensional structure seems to facilitate protein-protein interactions. In chondroadherin the leucine-rich sequence is repeated 11 times. This protein differs from the other members of this family of extracellular matrix proteins having two disulfide-bonded loops in the C-terminal region and also by lacking any N-terminal extension. Its different gene organization defines its own subfamily (6) . Chondroadherin has, as compared with other LRR proteins exemplified by decorin and fibromodulin, a rather restricted tissue distribution, under normal conditions confined to cartilage and tendon (2, 7) . Studies of the developing femoral head of rats showed that chondroadherin is localized mainly in the territorial matrix in different stages of articular cartilage development (7). Fibromodulin and decorin on the other hand are part of the structural, interterritorial matrix in cartilage (8, 9 ). The precise function of chondroadherin is unknown. It has been shown to bind cells via the ␣ 2 ␤ 1 integrin without stimulating cell spreading (10, 11) .
The collagen family of proteins includes several members that are restricted to cartilage extracellular matrix. The collagens can be classified on the basis of their molecular shape and properties. Collagen type II is the major collagen found in cartilage. It is a fibril-forming collagen composed of three identical polypeptide chains folded into a unique triple helix (12) . The assembly of many collagen molecules into a fibril is a specific and tightly regulated process that takes place in the extracellular environment. The surface of the fibrils as well as of the collagen molecules themselves has properties allowing tight binding of a number of other matrix proteins. These include LRR proteins such as decorin (13) , fibromodulin (14) , and lumican (15) as well as other collagens such as collagen type IX (16) . Recently it has been shown that another abundant * This work was supported by grants from the Swedish Medical Research Council, the Medical Faculty, Lund University, Förenade Liv, Konung Gustaf V:s 80-årsfond, Reumatikerförbundet, Stiftelsen Börje Dahlins fond, Alfred Ö sterlunds stiftelse, Anna-Greta Crafoords stiftelse för reumatologisk forskning, and Greta och Johan Kocks stiftelser. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. cartilage protein, cartilage oligomeric matrix protein (COMP), also can bind collagen type II (17) .
Chondroadherin interactions beyond the ability to bind to cells, e.g. back to the matrix, have not been identified. Since several other LRR proteins have been shown to bind to fibrilforming collagens, we have examined the possible interaction between chondroadherin and collagen II. We now show that chondroadherin binds to collagen type II in vitro and that the binding also appears to occur in vivo.
EXPERIMENTAL PROCEDURE
Cloning and Sequencing of Human Chondroadherin cDNA-A ZAP II cDNA library made from human chondrocytes (provided by Dr. Michael Bayliss) was screened using a 450-base pair bovine chondroadherin cDNA probe. A 1444-base pair clone was isolated and purified with Plasmid Midi kit (Qiagen). DNA sequencing was performed in full on both strands by standard double-strand dideoxy termination sequencing using T3, T7, and synthetic internal specific primers.
Expression of Recombinant Chondroadherin and Generation of Antibodies against Human Chondroadherin-A 1.4-kilobase pair human chondroadherin cDNA NotI fragment was ligated to the Epstein-Barr virus-based eucaryotic expression vector pCEP4 (Invitrogen, California). This vector is maintained extrachromosomally in eucaryotic cells and expresses high levels of recombinant protein (18) . The transcription is driven by the cytomegalovirus promoter included in the pCEP4 vector. The endogenous signal peptide of human chondroadherin was used. Using LipofectAMINE (Life Technologies, Inc.), the construct in pCEP4 was transfected into human kidney cells expressing the Epstein-Barr nuclear antigen-1 (293-EBNA cells, Invitrogen). After transfection the cells were grown in Dulbecco's modified Eagle's medium (Life Technologies, Inc.) containing 10% fetal calf serum. After 48 h, hygromycin (Calbiochem) (160 g/ml) was added to the culture medium to select cells. These were expanded, and when confluent, the medium was changed to Dulbecco's modified Eagle's medium without fetal calf serum. The cells were left for 48 h, after which the medium was harvested and centrifuged for 5 min at 3000 ϫ g. Phenylmethylsulfonylfluoride (1 mM, final concentration) was added as a protease inhibitor. One liter of collected medium was diluted 4 times to a final concentration of 20 mM Tris, pH 7.3, and applied to carboxymethyl cellulose cation exchange (CM52, Whatman) column previously equilibrated in 20 mM Tris, pH 7. The column was washed with 20 mM Tris and eluted with a gradient of 0 -0.5 M NaCl in 20 mM Tris, pH 7.
A polyclonal antibody against human chondroadherin was raised by immunizing a rabbit with a peptide from the C-terminal region of the protein (GQHIRDTDAFRS) coupled to keyhole limpet hemocyanin using glutaraldehyde (19) . This antiserum has been shown to react only with chondroadherin in crude tissue extracts. The purity and identity of the protein was confirmed by SDS-PAGE and Western blotting using antibodies raised against the C-terminal region of human chondroadherin as well as against bovine chondroadherin (2) .
Extraction and Isolation of Chondroadherin Complexes from Cartilage-Fresh calf articular cartilage was dissected into 2-3 mm pieces and washed twice in phosphate-buffered saline followed by 2 washes in Hepes-buffered saline supplemented with CaCl 2 (HBSCa) (50 mM Hepes, 0.15 M NaCl, 1 mM CaCl 2 , pH 7.4). The cartilage was incubated at 37°C overnight in 15 volumes (w/v) HBSCa, supplemented with 1 mM p-aminophenylmercuric acetate (APMA) (Sigma) and 10 M cycloheximide, the latter to eliminate contribution from proteins synthesized during processing. The supernatant was collected by a brief centrifugation to remove the coarser cartilage pieces followed by centrifugation at 17,700 ϫ g for 30 min. Proteinases activated by APMA were inhibited by adding EDTA to a final concentration of 9.8 mM. The supernatant was finally made particle-free by centrifugation in a Beckman Ti50.2 rotor at 43000 rpm (100.000 ϫ g) for 1 h at 4°C.
Ion Exchange Chromatography of Cartilage Extract-200 ml of the supernatant from the cartilage incubate was applied to a 32-ml diethylaminoethylcellulose anion exchange (DE52, Whatman) column equilibrated in Hepes-buffered saline containing 9.8 mM EDTA, pH 7.4. The flow-through was kept and further analyzed. Elution was made with a gradient of sodium acetate (0 -1.5 M, pH 7.4).
Zonal Rate Centrifugation in Glycerol Gradients-Gradients (4 ml) of 10 -30% glycerol in Hepes-buffered saline with EDTA (49 mM Hepes, 0.15 M NaCl, 9.8 mM EDTA, pH 7.4) were prepared. Sample in the same buffer (200 l) was applied on top and then centrifuged at 50,000 rpm (ϳ257,000 ϫ g) in a Beckman Sw60.1 swinging bucket rotor for 15 h at 18°C. The gradients were emptied from the bottom in 200-l fractions.
SDS-PAGE and Western
Blot-Samples of the fractions from zonal rate centrifugation were prepared for SDS-PAGE by precipitation with 9 volumes of 95% ethanol containing 50 mM sodium acetate (20). Precipitated proteins were dissolved in sample buffer and separated on 4 -16% polyacrylamide gels. Proteins were either stained directly or transferred using a tank blot system (Mini Trans-Blot, Bio-Rad) to polyvinylidene difluoride membranes (fluorotrans transfer membranes, Pall Filtron). Blotted membranes were blocked for additional protein binding with 3% (w/v) milk powder in 10 mM Tris, 0.15 M NaCl, 0.2% Tween 20, pH 7.4. Primary antibody raised against bovine chondroadherin was applied in the same buffer solvent. Bound antibodies were detected after incubation with secondary antibodies conjugated to horseradish peroxidase by chemiluminescence using the ECL system (Amersham Pharmacia Biotech).
Isolation and Purification of Collagen II-Collagen II was purified from pepsin-digested bovine articular cartilage as previously described (13, 21) . The purity of the collagen II was confirmed by SDS-PAGE (Fig.  1) .
Electron Microscopy-Chondroadherin and collagen-containing samples from the flow-through of the DE52 column were prepared for electron microscopy either directly or after incubation with gold-labeled affinity-purified antibodies against bovine chondroadherin. Recombinant chondroadherin and collagen type II were preincubated and treated the same way as the samples isolated from the tissue extract. Samples were adsorbed to 400 mesh carbon-coated copper grids, which were previously rendered hydrophilic by glow-discharge at low pressure in air. The grids were immediately blotted, washed with two drops of water, and stained with 0.75% uranyl formate for 15 s. When used, affinity-purified antibodies were labeled with colloidal gold of 3-nm size as described by Baschong and Wrigley (22) .
Samples were observed in a Jeol 1200 EX transmission electron microscope operated at 60 kV accelerating voltage and ϫ75,000 magnification. Images were recorded on Kodak ESTAR Thick Base 4489 plates without preirradiation at a dose of typically 2000 electrons/nm 2 . Evaluation of the data from electron micrographs was done as previously described (23) . An antibody against the C-terminal region of collagen type II (a gift from Dr. Rikard Holmdahl) was used to determine the polarity of the collagen molecules.
Interactions studied by Surface Plasmon Resonance-The BIAcore TM 2000 system (BIAcore AB, Sweden) was used to further characterize the interaction and to determine the binding characteristics between chondroadherin and type II collagen. In one set of experiments pure recombinant chondroadherin was concentrated, and the buffer was changed to 10 mM Hepes, 0.15 M NaCl, 0.05% Tween, pH 7.4. The carboxymethylated dextran surface on the chip (CM5 sensor chip, BIAcore AB, Uppsala, Sweden) was activated with 35 l of 50 mM N-hydroxysuccinimide and 35 l of 200 mM N-ethyl-NЈ-(dimethylaminopropyl)carbodiimide at 25°C at a flow of 5 l/min. Chondroadherin (35 l at 100 g/ml) was immobilized at 25°C at a flow rate of 5 l/min. One surface was used as the negative control, containing no coupled protein.
Remaining activated groups were blocked with 40 l of 1 M ethanolamine, pH 8.5.
The immobilization of recombinant chondroadherin resulted in 5400 resonance units (1000 resonance unit ϭ 1 ng/mm 2 ). The binding assay was performed at 25°C by using pepsinized collagen II at different concentrations ranging from 0.09 to 5.9 g/ml in 9.8 mM Hepes, 0.15 M NaCl, 0.05% Tween, pH 7.4, at 40 l/min. The surface was regenerated by using 0.5 M acetic acid, 2 M NaCl, followed by 0.1 M NaHCO 3 , 2 M NaCl, pH 9.2.
In another set of experiments, pepsinized collagen type II (2.1 mg/ml in 0.1 M acetic acid) was diluted to 100 g/ml in 10 mM sodium citrate, pH 3.2, and immediately immobilized under the same conditions as above (running buffer, 10 mM Hepes, 0.15 M NaCl, 0.05% Tween, pH 7.4). The immobilization of collagen type II resulted in 3000 resonance units. The binding assay was performed at 25°C by using recombinant chondroadherin at different concentrations ranging from 0.03 to 4 g/ml in 10 mM Hepes, 0.15 M NaCl, 0.05% Tween, pH 7.4, applied at 40 l/min. The surface was regenerated by using 10 mM Hepes, 2 M NaCl, pH 7.4, followed by 0.1 M NaHCO 3 , 2 M NaCl, pH 9.2. The BIAevaluation software (version 3.0) was used to calculate the different equilibrium dissociation constants (K D ) (24) .
RESULTS

Nucleotide and Deduced Amino Acid Sequence of Human
Chondroadherin-The screening of a human cDNA library resulted in the isolation of a 1444-base pair clone. The deduced amino acid sequence was similar to the one published (25) .
However, certain differences were found. At position 114 in the sequence we found leucine instead of valine, and at position 166 we found alanine instead of proline. Our sequences at these positions were found to be in agreement with the sequences from mouse (6), rat (7), and cow (3).
Expression and Purification of Native Recombinant Chondroadherin-The recombinant chondroadherin was bound to and then eluted from a CM52 column at an ionic strength of 0.18 -0.22 M NaCl. The yield of native recombinant chondroadherin was between 1 and 2 g/ml culture medium. The protein appears pure as shown by SDS-PAGE (Fig. 1) and Western blotting using antibodies raised against the bovine chondroadherin (2) as well as against the C-terminal region of the protein.
The nature of the purified protein was verified by mass spectrometry after Lys-C digestion (not shown).
Cartilage Extraction and Preparation of Chondroadherin Complexes-Chondroadherin was released from calf articular cartilage using APMA in Hepes-buffered saline with calcium. Release without APMA was 10 -15% of that with APMA and was not further analyzed. Gel filtration on Superose 6 of the supernatant representing released proteins showed that chondroadherin eluted in early fractions, indicating that it occurred in complexes of considerable size (data not shown). Ultracentrifugation at 100,000 ϫ g for 1 h showed that chondroadherin remained in the supernatant, thus was not included in particles. To further study the complexes, the supernatant was subjected to anion exchange chromatography. The chondroadherin pool then separated into two fractions, one passing through and one being retained on the column. The latter was eluted together with several proteins including biglycan as a major component, at a sodium acetate concentration of 0.7-0.8 M. The pool passing through the DE column contained collagen II ␣1-chains (as deduced from migration on SDS-PAGE under non-reduced and reduced conditions) as well as chondroadherin (as detected by Western blot) and a few other components (data not shown). Among those other components a prominent band was identified as the C-terminal propeptide of collagen II by Western blot (data not shown). The pool containing collagen and chondroadherin was further fractionated by zonal rate centrifugation and analyzed by electron microscopy.
Characterization of Extracted Complexes by Zonal
Rate Centrifugation-Samples of the flow-through from the DE52 column containing several different molecular entities were further fractionated by zonal rate centrifugation in glycerol gradients. The composition of the various fractions was studied by SDS-PAGE electrophoresis and Western blot analyses of non-reduced samples. Collagen type II was detected in the upper part of the gradient with the slowest sedimentation (Fig.  2) . Corresponding fractions from an identical gradient were shown to contain chondroadherin (Fig. 2) .
Electron Microscopy of Released Complexes and Complexes Formed in Vitro-
Electron microscopy showed filaments of intact monomeric collagen molecules with bound globules having the typical three-lobe appearance of the LRR proteins at distinct locations (Fig. 3A) . To verify their nature, the complexes were incubated with gold-labeled affinity-purified antibodies to chondroadherin before electron microscopy. The figure then shows the gold-labeled antibodies associated with the presumptive chondroadherin globules bound to collagen (Fig. 3B) . Thus the complexes isolated represent collagen with bound chondroadherin. No other molecules appeared to bind at these sites on the collagen. Similar complexes could be formed by recombination of equimolar amounts of recombinant chondroadherin and isolated pepsinized collagen II (Fig. 3C) .
The polarity of the collagen II molecules was identified by an antibody that recognizes an epitope close to their C-terminal end (kindly provided by Dr. Rikard Holmdahl, Lund University). The binding sites were identified by measuring the distance from the C-terminal end of the collagen to the site of chondroadherin binding. The relative abundance of chondroadherin bound at the two identified binding sites on the collagen are shown in Fig. 4 . These sites are located at 185 and 267 nm from the C-terminal end of collagen. The two sites show similar occupancy in the extracted material (Fig. 4A ) and in the in vitro reconstituted complexes (Fig. 4B) .
In Vitro Interaction between Chondroadherin and Collagen 
Type II as Measured by Surface Plasmon
Resonance Assays-In a first set of experiments the interaction of collagen type II with immobilized chondroadherin was studied using different concentrations of collagen, resulting in the association and dissociation curves shown in Fig. 5A . Evaluation using the Langmuir model predicting a 1:1 interaction unraveled an equilibrium dissociation constant of 0.9 nM. Using a model allowing for a bivalent analyte (collagen II) gave a higher K D of 44 nM for the stronger of the two putative binding sites.
In another set of experiments collagen type II was immobilized, and the interaction with chondroadherin was studied (Fig. 5B) . Evaluation of these data showed that the K D of the interaction in this system was 40 nM.
DISCUSSION
Alterations of cartilage matrix turnover in arthritic diseases is thought to be driven by cytokines. They induce production of proteinases and their activation through as yet not fully known mechanisms. These enzymes degrade matrix constituents, thereby affecting tissue integrity. To study the release of cartilage components, particularly chondroadherin, under the influence of activated endogenous proteinases, we treated cartilage with APMA to activate matrix metalloproteinases (26) . Chondroadherin was indeed among the molecules released to the medium in buffers that show little extraction on their own. Fractionations of the released material by ion exchange chromatography and zonal rate centrifugation showed that intact collagen and chondroadherin cofractionated. This was unex- pected in view of their widely different masses. It therefore appeared that the two molecules occurred in the same complexes, indicative of a tight interaction. To further identify and define the binding site(s), we performed negative staining and electron microscopy of material from the tissue extract as well as from in vitro recombined collagen and chondroadherin. The combined analyses showed that chondroadherin and collagen indeed interact and that the binding sites are identical between the material released from the tissue and the complexes formed by isolated, pure components. In both systems one major and one minor binding site, 185 and 267 nm, respectively, from the C terminus of the collagen molecule was identified. To study the quality of the interaction, pure components were analyzed using surface plasmon resonance in the BIAcore. The K D of the interaction was calculated both for the interaction when chondroadherin was immobilized and when collagen was immobilized. The K D in the nanomolar range differs somewhat depending on which component in the interaction pair was immobilized. The tighter binding of collagen to immobilized chondroadherin may result from the two binding sites for chondroadherin on collagen enhancing the binding strength as compared with chondroadherin interacting with immobilized collagen. This assumption is further strengthened by using a model allowing for two binding sites on the analyte (collagen), which gives a K D that is some 40 times higher as compared with a model predicting a 1:1 interaction. It is also possible that the microenvironment on the chip becomes somewhat different depending on how the ligand was immobilized.
The complexes released from the cartilage and characterized by electron microscopy consist of collagen type II with one or two chondroadherin molecules attached. Neither collagen nor chondroadherin seem to be degraded, indicating that their release is dependent on cleavage of their anchorage in the tissue. The complexes consist of intact chondroadherin and intact collagen, which further strengthens the assumption that these complexes occur in vivo. The collagen in the complexes is monomeric but in a mature form, without propeptides. This is particularly interesting in view of the very low abundance of non-aggregated collagen molecules being highly interactive. Since the collagen was not in its proform, it appears to have been processed in the tissue. Whether this was a result of the induced proteolysis is not clear. However, all observed collagen molecules were processed at the same time as fragmentation of other proteins like chondroadherin, and cartilage oligomeric matrix protein was limited, indicating that processing had occurred before APMA treatment.
In articular cartilage, chondroadherin is located territorially, whereas most other LRR proteins also known to interact with collagen such as decorin and fibromodulin are located interterritorially, where they have structural functions in the network. It is reasonable to speculate that proteins located closer to the cells have a regulatory role, communicating between cells and matrix. Both collagen type II and chondroadherin have been shown to bind chondrocytes (11) . These cells are known to express several different integrins on their surface including ␣ 1 ␤ 1 and ␣ 2 ␤ 1 (27, 28) . The ␣ 2 ␤ 1 integrin has been shown to be the receptor for chondroadherin (10) , whereas both these integrins have been shown to bind collagen type II. Even though collagen and chondroadherin interact with the same integrin, only collagen is able to induce spreading of cells adhering in vitro (11) . By sharing one of the receptors on the chondrocyte and by interacting with each other, a complex system is created. This potentially includes cross-bridging of a number of receptors. Future work should sort out the consequences of interactions of individual components in comparison to that of the complexes, e.g. with regard to ensuing intracellular signaling and cell function.
An obvious function of collagen type II in articular cartilage is to form highly organized fibers that are of fundamental importance for the mechanical properties of the tissue. Several studies have shown that the assembly of collagen fibers is influenced by other molecules like collagen type IX as well as by matrix proteins in the LRR protein family such as decorin, fibromodulin, and lumican. They all bind to fibrillar collagens type I and II (13) (14) (15) . A consequence of this interaction is that they are able to modulate fibril formation in vitro and affect the dimensions of the fibers (29 -32) . Many connective tissue disorders have been linked to alterations in collagen assemblies and, thus, function. This could be due to defects in collagen itself or to alterations in proteins involved in the assembly of collagen fibrils. Genes for several members of the LRR protein family have been functionally deleted in mice. A major phenotype in the null mutants of lumican (30) , decorin (31) , and fibromodulin (32) is dysregulation of the collagen fibril formation. The result is irregular thick or thin collagen fibrils. These studies verify that in vitro observation of interactions between LRR proteins and collagen are of biological importance. Chondroadherin, also a member of this LRR protein family, is now shown to interact with collagen. It is likely that also this protein influences the assembly and, thereby, the function of fibrillar collagen. Since chondroadherin is abundant in the territorial matrix, it may have a role particularly in the early with immobilized collagen type II. The curves in the figure for collagen and CHAD, respectively, represent the measured values from which the values obtained from the reaction between the analyte and an uncoated surface were subtracted. These were then used to calculate the association (k a ) and dissociation (k d ) rate constants, applying the Langmuir model predicting a 1:1 interaction. The rate constants were used to calculate the equilibrium dissociation constant K D for collagen interaction with chondroadherin and chondroadherin interaction with collagen, respectively. RU, resonance units. events in collagen assembly. Indeed, the observation of monomeric soluble collagen with bound chondroadherin indicates a role in regulating collagen assembly. The role may particularly involve preventing premature associations of the collagen molecule into fibrils.
Molecular complexes released from cartilage upon APMA treatment were separated into two chondroadherin-containing classes showing major differences in ionic charge. One fraction was now shown to represent complexes between monomeric collagen and chondroadherin. The other fraction was much more anionic. Since chondroadherin at neutral pH does not bind to DEAE-cellulose used for separation, it appears that chondroadherin is bound to an anionic "carrier" protein. In view of the presence of biglycan in this fraction, it is possible that there are complexes containing biglycan and chondroadherin and possibly other molecules. This fraction might thus represent yet another interaction with chondroadherin.
